tezacaftor/ivacaftor
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Vertex Pharmaceuticals Incorporated
Overview
tezacaftor/ivacaftor is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
tezacaftor/ivacaftor clinical trials
Explore related
Medical disclaimer. This page summarizes research about tezacaftor/ivacaftor for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.